EMCDDA Home
  • EN
Search

Table TDI-109. All clients entering inpatient treatment by primary drug and age at first use, 2011 or most recent year available

Part (vii) All cannabis inpatient clients by country and age at first use

Country<1515-1920-2425-2930-3435-3940-4445+Age knownAge not knownTotal
Belgium708213120011690169
Bulgaria030000003811
Czech Republic1181237601102566262
Denmark2925211000581371
Germany81871672201135316481221770
Estonia:::::::::::
Ireland116116021621303546360
Greece295483000094094
Spain:::::::::::
France7526511::::5:
Italy:::::::::::
Cyprus31792001032032
Latvia:::::::::::
Lithuania:::::::::::
Luxembourg105:::::::::
Hungary143272001056056
Malta:::::::::::
Netherlands1791792394040398303701
Austria282841110063871
Poland2918742:1:::2:
Portugal:::::::::::
Romania5191541000443377
Slovenia:::::::::::
Slovakia306820320001230123
Finland232412000050151
Sweden117214612212103360336
United Kingdom34536421::::4:
Croatia51721000::35:
Turkey9614864201073134914363
Norway4828342010017217189
Total2083207829790371719542055774736
 

Notes:

: Indicates no data are available.

(1) Data are from 2010.

(2) Data are from 2009. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.

(3) Data are from 1st of April 2010 to 31st March 2011.

(4) In Norway the criteria for selecting and grouping cases are main ICD-10 diagnosis codes F11-F16 and F18-F19.

The number of treatment clients in each country is listed in TDI-7

See also Table TDI-11 part(vii), part(viii)

‘General notes for interpreting data'’ on the Explanatory notes and help page.

Source:

Reitox national reports 2011- Table TDI Inpatient Treatment Centres

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 26 April 2013